Log in to save to my catalogue

Radioiodine treatment for graves’ disease: a 10-year Australian cohort study

Radioiodine treatment for graves’ disease: a 10-year Australian cohort study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_07b1f0fed3824ce092793affb70f3c54

Radioiodine treatment for graves’ disease: a 10-year Australian cohort study

About this item

Full title

Radioiodine treatment for graves’ disease: a 10-year Australian cohort study

Publisher

England: BioMed Central Ltd

Journal title

BMC endocrine disorders, 2018-12, Vol.18 (1), p.94-6, Article 94

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Radioactive iodine (I
) is a common definitive treatment for Graves' Disease. Potential complications include worsening, or new development of Graves' eye disease and development of a radiation thyroiditis. The purpose of the present study was to assess outcomes of patients treated with I
in an Australian tertiary centre over 10 years.
Dat...

Alternative Titles

Full title

Radioiodine treatment for graves’ disease: a 10-year Australian cohort study

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_07b1f0fed3824ce092793affb70f3c54

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_07b1f0fed3824ce092793affb70f3c54

Other Identifiers

ISSN

1472-6823

E-ISSN

1472-6823

DOI

10.1186/s12902-018-0322-7

How to access this item